Agenus (AGEN) Other Non Operating Income (2018 - 2026)
Agenus' (AGEN) quarterly Other Non Operating Income came in at $38.8 million in Q1 2026, up 14804.92% year-on-year from N/an in Q1 2025, and up 531.78% quarter-over-quarter from -$9.0 million in Q4 2025.
Agenus (AGEN) Other Non Operating Income (2018 - 2026) Analysis & Trends
Agenus' Other Non Operating Income history runs 6 years deep, the most recent figure standing at $38.8 million for Q1 2026.
- On a quarterly basis, Other Non Operating Income rose 14804.92% year-over-year to $38.8 million in Q1 2026; TTM through Mar 2026 was $111.4 million, a 1570.32% increase from a year earlier, with the FY2025 full-year figure at $72.4 million, up 1141.15% from the prior year.
- Other Non Operating Income advanced to $38.8 million in Q1 2026 per AGEN's latest filing, from -$9.0 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $81.6 million in Q3 2025 and bottomed at -$9.0 million in Q4 2025.
- The 3-year median for Other Non Operating Income is -$12000.0 (2025), against an average of $13.0 million.
- Biggest YoY gain for Other Non Operating Income was 429510.53% in 2025; the steepest drop was 3913.84% in 2025.
- Year by year, Other Non Operating Income stood at -$224000.0 in 2024, then tumbled by 3913.84% to -$9.0 million in 2025, then soared by 531.78% to $38.8 million in 2026.
- Per Business Quant, the three latest AGEN Other Non Operating Income figures stand at $38.8 million (Q1 2026), -$9.0 million (Q4 2025), and $81.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Agenus | 184.05 Mn | 177.29 Mn | 33.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.82 Mn |
| Dec 31, 2025 | -8.99 Mn |
| Sep 30, 2025 | 81.63 Mn |
| Jun 30, 2025 | -12,000.00 |
| Mar 31, 2025 | -264,000.00 |
| Dec 31, 2024 | -224,000.00 |
| Sep 30, 2024 | 19,000.00 |
| Jun 30, 2024 | 7.14 Mn |
| Mar 31, 2024 | -1.11 Mn |
| Sep 30, 2021 | 6.20 Mn |
| Dec 31, 2020 | 5.42 Mn |
| Mar 31, 2020 | -2.72 Mn |
| Mar 31, 2018 | -10.77 Mn |